Giovanni Causapruno
Sales Director
xFarm
- Explore how biomarker-driven approaches are streamlining trial design, improving patient stratification, and accelerating time-to-approval for women’s health therapeutics.
- Learn how collaborations between industry, academia, biotech, and pharma are turning early-stage biomarker insights into clinically actionable endpoints.
- How to maximise the use of biobanks in biomarker discovery.
Sanj Singh
CEO
Temple Therapeutics
Sanj Singh
CEO
Temple Therapeutics
- Explore how biomarker-driven approaches are streamlining trial design, improving patient stratification, and accelerating time-to-approval for women’s health therapeutics.
- Learn how collaborations between industry, academia, biotech, and pharma are turning early-stage biomarker insights into clinically actionable endpoints.
- How to maximise the use of biobanks in biomarker discovery.
Sanj Singh
CEO
Temple Therapeutics
Cindy Rahman
President & CEO
March of Dimes
